Please click on the Resources tab to learn more about OXLUMO™ (lumasiran) and Alnylam Assist®. All resources are intended for US residents only, with the Alnylam Assist® brochure and OXLUMO HCP brochure meant specifically for a U.S. healthcare professional audience. For additional information about OXLUMO, please see the full Prescribing Information link on the Resources tab or at www.oxlumohcp.com.
OXLUMO is a trademark, and Alnylam Assist® is a registered trademark, of Alnylam Pharmaceuticals, Inc. © 2021 Alnylam Pharmaceuticals, Inc.